We recently read one of the better reports on the use of digital technologies in the world of clinical development. Why is it better? Because Deloitte provides some actual case studies/ use cases for these technologies. In one example, a service provider, Science 37, used telemedicine to conduct a complete virtual Phase II study. We have no idea whether the trial will be part of an FDA submission, but cool nonetheless. Another interesting idea from Deloitte is using “Synthetic trial arms or master protocols to reduce the number of patients required to test investigational treatments. A synthetic trial arm uses data from previously completed trials or real-world evidence and is particularly useful in rare disease trials or when a placebo approach is not appropriate or ethical, as is often the case in oncology.” Love it. Speaking of synthetic, here’s a list of the worst synthetic fabrics to wear.